CEBPD and metabolic dysfunction-associated steatotic liver disease: This study identified common DEGs between NAFLD and AIS and experimentally validated CEBPD as a potential marker, revealing possible common molecular mechanisms between the two diseases, providing new directions for future diagnosis and treatment.